Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models (Q37045295)
Jump to navigation
Jump to search
scientific article published on 28 June 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models |
scientific article published on 28 June 2016 |
Statements
1 reference
Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models (English)
1 reference
Christian Lehmann
1 reference
Thomas Friess
1 reference
Fabian Birzele
1 reference
Anna Kiialainen
1 reference
Markus Dangl
1 reference
28 June 2016
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference